Pd-L1 Profiling Of Circulating Tumor Cells For Immune Checkpoint Inhibitor Therapy In Head And Neck Cancers

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 0|浏览0
暂无评分
摘要
36Background: Selection of Immune Checkpoint Inhibitor (ICI) therapies in Head and Neck cancers are based on IHC based detection of PD-L1 expression in tumor tissue. Invasive biopsy to obtain tumor...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要